The Latest: Pfizer close to big step toward kids' vaccine
WASHINGTON - Pfizers CEO says "its a question of days, not weeks" before the company and German partner BioNTech submit data to U.S. regulators for federal...
WASHINGTON - Pfizers CEO says "its a question of days, not weeks" before the company and German partner BioNTech submit data to U.S. regulators for federal...